B-cell lymphoma vaccination may benefit certain patients with NHL

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioimmunotherapy of B-Cell NHL

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 327-339

Bentham Science Publishers

Access to resources Recommend Favorite

Patients with relapsed or refractory mantle cell lymphoma may receive benefit from bortezomib

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Response and survival benefit with chemoimmunotherapy in Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 93-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of large B-cell lymphoma

By Escalón Maricer P Lossos Izidore S

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2247-2258

Informa Healthcare

Access to resources Recommend Favorite